Trials / Completed
CompletedNCT04469023
Late Phase II Study of TS-142 in Patients with Insomnia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 179 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, multi-center, placebo-controlled, parallel-group exploratory study in patients with insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-142 | Participants received multiple-dose of 2.5, 5, 10 mg of TS-142 or placebo (oral tablet) |
Timeline
- Start date
- 2020-09-09
- Primary completion
- 2021-11-16
- Completion
- 2021-11-16
- First posted
- 2020-07-13
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04469023. Inclusion in this directory is not an endorsement.